12-14 Oct, 2021 | Diamond Jubilee Hall, Dar es Salaam, Tanzania

WHATSAPP +91-9560037594

FOR EAST AFRICA PHARMA HEALTHCARE UPDATES
Book a Stand

MARKET SCENARIO

6 countries in East Africa including Tanzania with a population of 184Mn in 2017

7% of the Tanzanian GDP spent on health services and medicines. estimated $700mn in 2017

Regional Pharma policy 2017-27 aims to double pharmaceutical prouduction to meet half of demand.

Tanzania health care spending expected to touch $3.9Bn in 2021


100% medical equipment demand in Tanzania and East Africa met through imports
Over 5000 healthcare centers and dispensaries in Tanzania, les than half in good condition and 1/3rd going for upgradation.

East Africa mainly comprise of 6 countries Tanzania, Burundi, Kenya, Rwanda, South Sudan, and Uganda, with an estimated population of 184mn in 2017, as per UN Department of Economic and Social Affairs, 2017.GDP growth: 239% between 2005 and 2016; from $43.4b to $163.9bn, EAC average growth of 6.2% in last 10 years compared to 1.7% in the EU. Around 7% of the GDP is spent health services and annual per capita spending on health services and medicines is around USD 90.

Growing population with high GDP growth, huge unmet medical need and emerging middle class are the key drivers of pharma healthcare market growth. The domestic production of the pharmaceuticals is very limited that too with high dependence on imported raw materials, so the major portion of the demand in the region is met through importation from ASIA and Europe, growing at a very high pace.

Tanzanian pharma market is expected to touch $700mn and that of East Africa by $2bn in 2017. The pharmaceutical imports of the East Africa, particularly for Tanzania and the land locked countries sharing borders with Tanzania, is through Tanzania – as Tanzania is the sourcing country for all these countries.

East African regional pharmaceutical plan 2017-27 aims at expanding the domestic production to meet its demand for the population and emphasis on sourcing 50% of domestic production.

Tanzania health spending is expected to touch $3.9Bn in 2021 (about 40% jump from 2017) and pharma sector has been among the promising industry sector in Tanzania. At present the country has 14 registered pharmaceutical industries, still 89% of the demand is met through imports.

The requirement for medical devices is 100% met through imports which is estimated at $400Mn.

Of 5072 public primary health care facilities (518 are Health Centers and 4554 are Dispensaries), the majority (46%) had a physical status of A (good state), 33% (1693) had physical status of B (minor renovation needed) and the remaining facilities had physical status of C up to F (needing major renovation).

About 33% (1673) of all health facilities had piped water and 5.1% had landline telecommunication system. Between 2015 and August 2019, a total of 419 (8.3%) health facilities (Consisting of 350 health centres and 69 District Council Hospitals) were either renovated or constructed and equipped to offer safe surgery services.

Only 115 Health Centers (22.2%) were offering the CEMONC services, of which about 20% were offering the CEMONC services with all 9 - signal functions and only 17.4% had facilities that are offering safe blood transfusion services.

In March 2018, MOHCDGEC launched a National Surgical, Obstetric, and Anesthesia Plans (NSOAPs). NSOAP lays out the necessary foundation to improve six major domains of the surgery, anesthesia and obstetric health care system, which are: - (a) service delivery, (b) infrastructure, (c) workforce, (d) information management and technology, (e) finance and (f) governance. This was set to address the challenge of 20% of deaths in Tanzania result from diseases that can be treated by surgical care, therefore having to ensure all Tanzanians can access safe surgical care by 2025.

REGISTER FOR FREE


To have a hassle free entry to meet & engage with exhibitors from World over in WAPHC


REGISTER TODAY
The Organizer

WegVoraus is a Business Promoter & Exhibition Organizer Headquartered in New Delhi, India. We work for prospect industry sectors to help them reach out to the right target audience as well as deliver business expansion solutions. Read More.